Tag: infliximab biosimilar
Biosimilar Switching: What Happens When You Change from Originator Biologic
Switching from an originator biologic to a biosimilar is safe for most patients with stable autoimmune conditions. Learn what really happens during the switch, why some people stop treatment, and how to make the transition work for you.
view morerecent posts
NSAIDs like ibuprofen and naproxen are common pain relievers, but they can cause serious stomach bleeding, especially in older adults or those with risk factors. Learn who’s most at risk, how to protect yourself, and what alternatives exist.
Published ON: 2 DecManufacturers fix quality problems by finding root causes, not just symptoms. Learn how CAPA systems, root cause analysis, and verification steps reduce defects, ensure compliance, and prevent recurrence in regulated industries.
Published ON: 5 DecLearn safe, step-by-step strategies to taper off benzodiazepines without severe withdrawal. Based on 2024 clinical guidelines, this guide covers dosing, switching to diazepam, managing symptoms, and building long-term recovery.
Published ON: 1 DecCommunity health presentations are helping patients understand that generic drugs are just as safe and effective as brand-name medications-saving billions and improving adherence. Learn how public education is breaking down myths and expanding access.
Published ON: 1 DecLearn how to safely store medications in shared homes with lockable storage, proper temperature control, labeling, and disposal practices to prevent accidents and ensure effectiveness.
Published ON: 11 Dec